373 related articles for article (PubMed ID: 25857658)
1. The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases.
Garg N; Reddel SW; Miller DH; Chataway J; Riminton DS; Barnett Y; Masters L; Barnett MH; Hardy TA
J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1374-82. PubMed ID: 25857658
[TBL] [Abstract][Full Text] [Related]
2. Differentiating multiple sclerosis from other causes of demyelination using diffusion weighted imaging of the corpus callosum.
Straus Farber R; Devilliers L; Miller A; Lublin F; Law M; Fatterpekar G; Delman B; Naidich T
J Magn Reson Imaging; 2009 Oct; 30(4):732-6. PubMed ID: 19787715
[TBL] [Abstract][Full Text] [Related]
3. Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.
Ayrignac X; Carra-Dallière C; Labauge P
Rev Neurol (Paris); 2018 Jun; 174(6):408-418. PubMed ID: 29673573
[TBL] [Abstract][Full Text] [Related]
4. An MRI review of acquired corpus callosum lesions.
Renard D; Castelnovo G; Campello C; Bouly S; Le Floch A; Thouvenot E; Waconge A; Taieb G
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1041-8. PubMed ID: 24563521
[TBL] [Abstract][Full Text] [Related]
5. Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study.
Odenthal C; Simpson S; Oughton J; van der Mei I; Rose S; Fripp J; Lucas R; Taylor B; Dear K; Ponsonby AL; Coulthard A;
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):453-460. PubMed ID: 27995735
[TBL] [Abstract][Full Text] [Related]
6. Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings.
Kalyan-Raman UP; Garwacki DJ; Elwood PW
Neurosurgery; 1987 Aug; 21(2):247-50. PubMed ID: 3658137
[TBL] [Abstract][Full Text] [Related]
7. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Wu QZ; Yang Q; Cate HS; Kemper D; Binder M; Wang HX; Fang K; Quick MJ; Marriott M; Kilpatrick TJ; Egan GF
J Magn Reson Imaging; 2008 Mar; 27(3):446-53. PubMed ID: 17968901
[TBL] [Abstract][Full Text] [Related]
8. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
Kalincik T; Vaneckova M; Tyblova M; Krasensky J; Seidl Z; Havrdova E; Horakova D
PLoS One; 2012; 7(11):e50101. PubMed ID: 23166826
[TBL] [Abstract][Full Text] [Related]
9. Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.
Simon JH; Zhang S; Laidlaw DH; Miller DE; Brown M; Corboy J; Bennett J
J Magn Reson Imaging; 2006 Nov; 24(5):983-8. PubMed ID: 17024655
[TBL] [Abstract][Full Text] [Related]
10. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis.
Gean-Marton AD; Vezina LG; Marton KI; Stimac GK; Peyster RG; Taveras JM; Davis KR
Radiology; 1991 Jul; 180(1):215-21. PubMed ID: 2052698
[TBL] [Abstract][Full Text] [Related]
11. Corpus callosum demyelination associated with acquired stuttering.
Decker BM; Guitar B; Solomon A
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29680798
[TBL] [Abstract][Full Text] [Related]
12. Corpus callosum in multiple sclerosis.
Barnard RO; Triggs M
J Neurol Neurosurg Psychiatry; 1974 Nov; 37(11):1259-64. PubMed ID: 4457618
[TBL] [Abstract][Full Text] [Related]
13. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
[TBL] [Abstract][Full Text] [Related]
14. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
Guglielmetti C; Praet J; Rangarajan JR; Vreys R; De Vocht N; Maes F; Verhoye M; Ponsaerts P; Van der Linden A
Neuroimage; 2014 Feb; 86():99-110. PubMed ID: 23933305
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data.
Dietemann JL; Beigelman C; Rumbach L; Vouge M; Tajahmady T; Faubert C; Jeung MY; Wackenheim A
Neuroradiology; 1988; 30(6):478-80. PubMed ID: 3226533
[TBL] [Abstract][Full Text] [Related]
16. Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis.
Pozzilli C; Fieschi C; Perani D; Paulesu E; Comi G; Bastianello S; Bernardi S; Bettinardi V; Bozzao L; Canal N
J Neurol Sci; 1992 Oct; 112(1-2):51-7. PubMed ID: 1469440
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and imaging of the corpus callosum.
Quint DJ
Radiology; 1991 Jul; 180(1):15-7. PubMed ID: 2052684
[No Abstract] [Full Text] [Related]
18. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.
Cocozza S; Olivo G; Riccio E; Russo C; Pontillo G; Ugga L; Migliaccio S; de Rosa D; Feriozzi S; Veroux M; Battaglia Y; Concolino D; Pieruzzi F; Tuttolomondo A; Caronia A; Russo CV; Lanzillo R; Brescia Morra V; Imbriaco M; Brunetti A; Tedeschi E; Pisani A
Neuroradiology; 2017 Jun; 59(6):563-570. PubMed ID: 28386689
[TBL] [Abstract][Full Text] [Related]
19. A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?
Invernizzi P; Bonometti MA; Turri E; Benedetti MD; Salviati A
Mult Scler; 2008 Aug; 14(7):1003-6. PubMed ID: 18632784
[TBL] [Abstract][Full Text] [Related]
20. Transcallosal bands: a sign of neuronal tract degeneration in early MS?
Simon JH; Jacobs L; Kinkel RP
Neurology; 2001 Nov; 57(10):1888-90. PubMed ID: 11723282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
